We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan · Delayed Price · Currency is TWD 21.65
-0.70 (-3.13%)
Sep 10, 2026, 1:33 PM CST
We Can Medicines Market Cap
We Can Medicines has a market cap or net worth of 1.01 billion as of September 9, 2026. Its market cap has decreased by -31.07% in one year.
Market Cap
1.01B
Enterprise Value
1.89B
Revenue
3.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
21.65
ChartMarket Cap Chart
Since December 9, 2022, We Can Medicines's market cap has decreased from 1.84B to 1.01B, a decrease of -45.23%. That is a compound annual growth rate of -14.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 1.01B | -34.89% |
| Dec 31, 2025 | 1.55B | -10.72% |
| Dec 31, 2024 | 1.73B | -59.87% |
| Dec 29, 2023 | 4.32B | 13.80% |
| Dec 30, 2022 | 3.80B | 106.30% |
| Dec 9, 2022 | 1.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fwusow Industry | 4.01B |
| Eagle Cold Storage Enterprise | 3.99B |
| Ten Ren Tea | 2.54B |
| Wonder Pets Enterprises | 2.10B |
| SunWay Biotech Co., LTD. | 2.03B |
| Hantech Bio-Technology | 1.94B |
| Tai Roun Products | 1.94B |
| Lian Fa International Dining Business | 1.51B |